BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2017

Jun 28, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2017-06-23

Reporting Person: Davis George Eric (EVP, General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-06-23	Common Stock	M	9844	$38.59	Acquired	93425	Direct
2017-06-23	Common Stock	S	9844	$96.60	Disposed	83581	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-06-23	Stock Option (Right to buy Common Stock)	$38.59	M	9844	Disposed	2018-05-21	Common Stock (9844)	Direct

Footnotes

F1: Trade made pursuant to a 10b5-1 plan executed on June 9, 2017.

F2: All shares sold at the same price.

F3: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.